Detalhe da pesquisa
1.
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 25(10): e1446-e1450, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452588
2.
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Oncotarget
; 12(18): 1836-1847, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504655
3.
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Genome Med
; 12(1): 80, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988401
4.
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Oncotarget
; 13: 1174, 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289011